Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives
暂无分享,去创建一个
Andrea Volpe | E. Sacco | P. Bassi | Francesco Pinto | Angelo Totaro | Alessandro Calarco | Emilio Sacco | Alessandro D’Addessi | Marco Racioppi | PierFrancesco Bassi | A. D'addessi | F. Pinto | Gaetano Gulino | M. Racioppi | A. Volpe | G. Gulino | A. Totaro | A. Calarco
[1] Alexandre Pelzer,et al. Value of magnetic resonance imaging in prostate cancer diagnosis , 2007, World Journal of Urology.
[2] D. Dearnaley,et al. Dynamic contrast-enhanced MRI for prostate cancer localization. , 2009, The British journal of radiology.
[3] L. Holmberg,et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. , 1997, Urology.
[4] Susanne Hempel,et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. , 2006, The Journal of urology.
[5] Cher Heng Tan,et al. Diffusion weighted imaging in prostate cancer , 2011, European Radiology.
[6] Clare Allen,et al. How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.
[7] Peter Boyle,et al. Cancer incidence and mortality in Europe , 2005, Sozial- und Präventivmedizin.
[8] J R Thornbury,et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.
[9] G Brix,et al. Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[10] Clare Allen,et al. Dynamic contrast enhanced MRI in prostate cancer. , 2007, European journal of radiology.
[11] E. Squillaci,et al. Magnetic resonance imaging of the prostate with spectroscopic imaging using a surface coil. Initial clinical experience , 2006, La radiologia medica.
[12] T. Loch,et al. [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer]. , 2004, Der Urologe. Ausg. A.
[13] Louis R Kavoussi,et al. Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. , 1994, The Journal of urology.
[14] M. Rifkin,et al. State of the art: endorectal sonography of the prostate gland. , 1990, AJR. American journal of roentgenology.
[15] Helmut Ermert,et al. Initial experiences with real-time elastography guided biopsies of the prostate. , 2005, The Journal of urology.
[16] L R Schad,et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.
[17] W S Ng,et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.
[18] B. Goldberg,et al. Initial experience with contrast-enhanced sonography of the prostate. , 2000, AJR. American journal of roentgenology.
[19] P. Carroll,et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future , 2008, Current opinion in urology.
[20] G. Haas,et al. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer , 2009, BJU international.
[21] Wolfhard Semmler,et al. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI , 2004, European Radiology.
[22] A. Villers,et al. Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer , 2007 .
[23] H M Pollack,et al. Magnetic resonance imaging of the prostate gland , 1990, Urologic radiology.
[24] A. Bueschen. Early diagnosis of prostate cancer. , 1987, The Alabama journal of medical sciences.
[25] T Okada,et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. , 2001, Urology.
[26] Amita Shukla-Dave,et al. Functional magnetic resonance imaging in prostate cancer. , 2009, European urology.
[27] Robert G. Moore,et al. Initial clinical experience , 1997 .
[28] A. Broillet,et al. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent. , 1998, Investigative radiology.
[29] D. Beyersdorff,et al. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. , 2005, Radiology.
[30] J. Murgo,et al. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[31] J Kurhanewicz,et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.
[32] P. Choyke,et al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies , 2008, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.
[33] M Hoehn-Berlage,et al. High resolution quantitative relaxation and diffusion mri of three different experimental brain tumors in rat , 1995, Magnetic resonance in medicine.
[34] Roberto Passariello,et al. Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.
[35] G Brix,et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: Initial results , 1998, Journal of magnetic resonance imaging : JMRI.
[36] M. Kattan,et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.
[37] Mark Emberton,et al. THE ROLE OF MAGNETIC RESONANCE IMAGING IN TARGETING PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES AND ELEVATED PROSTATE‐SPECIFIC ANTIGEN LEVELS , 2009, BJU international.
[38] Seong Ho Park,et al. Contrast-enhanced sonography for prostate cancer detection in patients with indeterminate clinical findings. , 2006, AJR. American journal of roentgenology.
[39] Hedvig Hricak,et al. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[40] D P Dearnaley,et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.
[41] P. Carroll,et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.
[42] Ferdinand Frauscher,et al. Detection of prostate carcinoma with contrast‐enhanced sonography using intermittent harmonic imaging , 2005, Cancer.
[43] Bernd Hamm,et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.
[44] B. K. Park,et al. Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy , 2008, Investigative Radiology.
[45] H. Hricak,et al. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.
[46] Silvia D. Chang,et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.
[47] A. Villers,et al. Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography , 2009, Current opinion in urology.
[48] P. Choyke. Contrast agents for imaging tumor angiogenesis: is bigger better? , 2005, Radiology.
[49] G. Bartsch,et al. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection , 2007, European Radiology.
[50] Tian Liu,et al. Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancer. , 2002, The Journal of urology.
[51] M. Resnick,et al. Magnetic resonance imaging of the prostate. , 1987, Progress in clinical and biological research.
[52] K. Badani,et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.
[53] G. Bartsch,et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. , 2005, The Journal of urology.
[54] Jun Nakashima,et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. , 2004, Urology.
[55] P. Carroll,et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.
[56] D. Johnston,et al. Optimization of prostate biopsy strategy using computer based analysis. , 1997, The Journal of urology.
[57] R. Passariello,et al. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy--comparison with MRI. , 2006, Ultraschall in der Medizin.
[58] W. Ellis,et al. Repeat prostate needle biopsy: who needs it? , 1995, The Journal of urology.
[59] K. Chrouser,et al. Extended and saturation needle biopsy for the diagnosis of prostate cancer , 2004 .
[60] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[61] Peter Choyke,et al. Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.
[62] Stefan A Reinsberg,et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. , 2007, AJR. American journal of roentgenology.
[63] M J Bronskill,et al. Magnetic resonance imaging of the prostate. , 1985, Radiology.
[64] W. Catalona,et al. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.
[65] M. Zerbib,et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. , 2005, European urology.
[66] A. Gelabert-Más,et al. The value of endorectal MRI in the early diagnosis of prostate cancer. , 2003, European urology.
[67] N. Miyanaga,et al. Tissue elasticity imaging for diagnosis of prostate cancer: A preliminary report , 2005, International journal of urology : official journal of the Japanese Urological Association.
[68] A. Asbeutah,et al. Transrectal ultrasound guided biopsy for detecting prostate cancer: can random biopsies be reduced using the 4-dimensional technique? , 2007, International Urology and Nephrology.
[69] Seong Ho Park,et al. Wash‐in rate on the basis of dynamic contrast‐enhanced MRI: Usefulness for prostate cancer detection and localization , 2005, Journal of magnetic resonance imaging : JMRI.
[70] R D Tien,et al. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. , 1994, AJR. American journal of roentgenology.
[71] W. J. Lorenz,et al. Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.
[72] P. Carroll,et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.
[73] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[74] Namkug Kim,et al. Functional MR imaging of prostate cancer. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.
[75] Jelle O. Barentsz,et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal–pelvic phased-array coils , 2007, European Radiology.
[76] K. Taari,et al. Optimal timing of post-biopsy MR imaging of the prostate. , 2001, Acta radiologica.
[77] S. Phongkitkarun,et al. Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[78] Peter Guion,et al. Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy , 2008, BJU international.
[79] Ashutosh Kumar Singh,et al. Magnetic resonance imaging‐directed transrectal ultrasonography‐guided biopsies in patients at risk of prostate cancer , 2007, BJU international.
[80] A. Padhani. Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.
[81] A. D'Amico,et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.
[82] J. Kurhanewicz,et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.
[83] G. Parker,et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience. , 2004, Radiology.
[84] J. Ferlay,et al. Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.
[85] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[86] N. deSouza,et al. MAGNETIC RESONANCE IMAGING IN PROSTATE CANCER : VALUE OF APPARENT DIFFUSION COEFFICIENTS FOR IDENTIFYING MALIGNANT NODULES , 2010 .
[87] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.